Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus
1 other identifier
interventional
48
1 country
1
Brief Summary
The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Apr 2021
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 11, 2021
CompletedFirst Posted
Study publicly available on registry
June 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedNovember 26, 2021
November 1, 2021
4 months
June 11, 2021
November 24, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
HbA1c Levels
Reduction in HbA1c levels
3 months
Study Arms (3)
Brisk walk
EXPERIMENTALAerobic Training
EXPERIMENTALStrength Training
EXPERIMENTALInterventions
1-Brisk walk for 30 minutes 2-5 days a week 3-3months
1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months
1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months
Eligibility Criteria
You may qualify if:
- Participants falling in this category would be recruited into the study.
- Male/female
- Diabetic type 2 patients
- Age: 30-70 years
- BMI \>25
- Overweight
- Fat % in male\> 25
- Fat % in female \>35
- HbA1c level more than 48mmol/mol or \>6.5%
- Fasting Plasma Glucose level \>126 mg/dl (7.0 mmol/l)
- Random Plasma glucose level \>200 mg/dl (11.1 mmol/l)
- Physically active ( have no mobility problems)
You may not qualify if:
- Participant failing to fall in this category would be excluded of the study.
- Type 1 diabetes
- Insulin dependant type 2 diabetes
- Gestational Diabetes
- Hypertension
- Cigarette smoking
- Cardiovascular Disease
- Cerebrovascular disease
- Cardiopulmonary Disorders
- Cognition Problems
- Peripheral Artery Disease
- Dyslipidemia
- Proliferative or preproliferative retinopathy
- Nephropathy
- Neuropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riphah Rehabilitation Center
Islamabad, 44000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Waqar Ahmad Awan
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2021
First Posted
June 14, 2021
Study Start
April 1, 2021
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
November 26, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share